Skip to content

Clinical trials

Phase 2 Post-Acute COVID-19 Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 2 Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20217
20229
202327
202412
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting11
Active, not recruiting7
Unknown status6
Not yet recruiting4
Terminated3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kanecia Obie Zimmerman5
Charite University, Berlin, Germany3
Duke University3
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2
Icahn School of Medicine at Mount Sinai2
ImmunityBio, Inc.2
AIM ImmunoTech Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AgelessRx1
Axcella Health, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome76
COVID-1921
Fatigue9
Fatigue Syndrome, Chronic5
Mental Fatigue5
Cognitive Dysfunction4
Cognition Disorders3
Infections3
Parasomnias3
Postural Orthostatic Tachycardia Syndrome3

Trials

Showing 26 to 50 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.